EmployblEmploybl logo
employbl
Nkarta Therapeutics logo

Nkarta Therapeutics Funding & Investors

Nkarta, Inc. operates as a biotech company. The Company develops and discovers therapies for immune systems and cancer indications. Nkarta serves patients in the State of California.

nkartatx.com

Total Amount Raised: $355,000,000

Nkarta Therapeutics Funding Rounds

  • Post Ipo Equity

    $230,000,000

  • Series B

    $114,000,000

    Series B Investors

    Logos Capital
    Novo Holdings
    Sr One
    New Enterprise Associates (NEA)
    Deerfield Management
    RA Capital Management
    Amgen
    Samsara BioCapital
    LSP (Life Sciences Partners)

  • Series A

    $11,000,000

    Series A Investors

    Novo Holdings
    Sr One
    New Enterprise Associates (NEA)
Funding info provided by Diffbot.